NCT00245024View on ClinicalTrials.gov

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

January 31, 2010

Conditions
Breast Cancer
Interventions
DRUG

sulindac

OTHER

laboratory biomarker analysis

Trial Locations (1)

85724-5024

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

All Listed Sponsors
collaborator

University of Arizona

OTHER

lead

National Cancer Institute (NCI)

NIH

NCT00245024 - Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer | Biotech Hunter | Biotech Hunter